Literature DB >> 9296546

Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992.

A Fugelstad1, A Annell, J Rajs, G Agren.   

Abstract

A cohort of 1640 hospitalized drug addicts was studied over an 8-year period, and consisted of 678 heroin users, 578 amphetamine users and 384 users of other drugs. In total, 234 addicts were HIV-positive, most of them heroin users. During the observation period, 214 deaths occurred in the cohort. The total mortality was 2.2% annually. Death linked to injection of heroin was the main cause of death not only among heroin users but also among subjects classified as users of amphetamines or other drugs. During the observation period, a total of 222 addicts (115 of whom were HIV-positive) entered the methadone programme. No deaths occurred among the HIV-negative subjects who were participating in the methadone programme. A total of 15 HIV-positive subjects died while taking part in the programme--13 of these subjects from natural causes (mostly HIV/AIDS).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296546     DOI: 10.1111/j.1600-0447.1997.tb10147.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  17 in total

1.  Illicit drug use in young adults and subsequent decline in general health: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.

Authors:  Stefan G Kertesz; Mark J Pletcher; Monika Safford; Jewell Halanych; Katharine Kirk; Joseph Schumacher; Stephen Sidney; Catarina I Kiefe
Journal:  Drug Alcohol Depend       Date:  2006-11-29       Impact factor: 4.492

Review 2.  Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

Authors:  L Degenhardt; W Hall; M Warner-Smith
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  The relationship between injection and noninjection drug use and HIV disease progression.

Authors:  Han-Zhu Qian; Samuel E Stinnette; Peter F Rebeiro; Aaron M Kipp; Bryan E Shepherd; Charles P Samenow; Cathy A Jenkins; Paul No; Catherine C McGowan; Todd Hulgan; Timothy R Sterling
Journal:  J Subst Abuse Treat       Date:  2011-02-23

4.  Is the high mortality risk in sentenced offenders independent of previous imprisonment?

Authors:  Ellen Kjelsberg; Petter Laake
Journal:  Eur J Epidemiol       Date:  2010-03-09       Impact factor: 8.082

5.  Causes of death of patients with methamphetamine dependence: a record-linkage study.

Authors:  Chian-Jue Kuo; Ya-Tang Liao; Wei J Chen; Shang-Ying Tsai; Shih-Ku Lin; Chiao-Chicy Chen
Journal:  Drug Alcohol Rev       Date:  2010-10-18

6.  Drug abuse-associated mortality across the lifespan: a population-based longitudinal cohort and co-relative analysis.

Authors:  Kenneth S Kendler; Henrik Ohlsson; Kristina Sundquist; Jan Sundquist
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-05-26       Impact factor: 4.328

7.  Association of History of Injection Drug Use with External Cause-Related Mortality Among Persons Linked to HIV Care in an Urban Clinic, 2001-2015.

Authors:  Kanal Singh; Geetanjali Chander; Bryan Lau; Jessie K Edwards; Richard D Moore; Catherine R Lesko
Journal:  AIDS Behav       Date:  2019-12

Review 8.  Mortality among people who inject drugs: a systematic review and meta-analysis.

Authors:  Bradley M Mathers; Louisa Degenhardt; Chiara Bucello; James Lemon; Lucas Wiessing; Mathew Hickman
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

9.  Mortality and Return to Work of Drug Abusers From Therapeutic Community Treatment 3 Years After Entry.

Authors:  John E. Berg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-08

10.  Number of addictive substances used related to increased risk of unnatural death: a combined medico-legal and case-record study.

Authors:  Louise Brådvik; Mats Berglund; Arne Frank; Anna Lindgren; Peter Löwenhielm
Journal:  BMC Psychiatry       Date:  2009-08-04       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.